nonhuman
primat
primarili
macaqu
use
studi
tuberculosi
decad
howev
last
year
model
refin
substanti
allow
care
investig
immun
respons
hostpathogen
interact
mycobacterium
tuberculosi
infect
low
dose
challeng
fulli
virul
strain
cynomolgu
macaqu
result
full
clinic
spectrum
seen
human
includ
latent
activ
infect
reagent
human
usual
crossreact
macaqu
facilit
use
model
system
studi
tuberculosi
final
macaqu
develop
spectrum
granuloma
type
seen
human
provid
uniqu
opportun
investig
bacteri
host
factor
local
lung
lymph
node
level
review
past
decad
immunolog
patholog
studi
macaqu
model
tuberculosi
nonhuman
primat
nhp
model
tuberculosi
tb
import
translat
model
human
diseas
bridg
gap
anim
model
human
nhp
closest
genet
human
experiment
anim
use
biolog
research
correspond
remark
immunolog
similar
human
mani
challeng
use
nhp
research
includ
tb
research
also
mani
advantag
practic
standpoint
mani
human
reagent
crossreact
nhp
use
readili
especi
macaqu
immunolog
similar
lead
one
expect
vaccin
adjuv
similar
effect
nhp
human
shown
sever
studi
mani
anim
model
tb
develop
nhp
model
primarili
focus
understand
facet
human
mycobacterium
tuberculosi
mtb
infect
could
address
small
anim
model
rabbit
mice
guinea
pig
zebra
fish
minipig
use
studi
tb
murin
model
correspond
perhap
establish
model
tb
given
highli
tractabl
wellestablish
genet
engin
transgen
knockout
strain
easili
examin
immunolog
compon
host
immun
respons
mice
also
easi
handl
rel
inexpens
maintain
biosafeti
level
contain
essenti
tb
studi
howev
latent
infect
common
manifest
human
mtb
infect
occur
natur
anim
model
list
modifi
mous
model
develop
attempt
mimic
human
latent
infect
either
use
antibiot
reduc
bacteri
load
strain
specif
infect
granuloma
histopatholog
hallmark
tb
seen
small
anim
model
neither
structur
architectur
granuloma
anim
spectrum
granuloma
type
consist
human
lesion
furthermor
subset
anim
produc
humanlik
granuloma
eg
rabbit
guinea
pig
zebrafish
limit
number
immunolog
reagent
remain
obstacl
studi
pathogenesi
tb
epidem
hivtb
coinfect
major
worldwid
public
health
concern
also
well
address
smaller
anim
model
although
effort
develop
human
mous
strain
foster
hiv
replic
develop
cattl
natur
host
bovi
use
model
tb
interest
result
studi
includ
vaccin
studi
review
howev
space
need
perform
studi
cattl
especi
condit
rel
small
number
immunolog
reagent
avail
limit
use
model
special
facil
lastli
key
immunolog
featur
import
aspect
human
antimycobacteri
immun
respons
includ
granulysin
express
cell
vitamin
ddepend
bind
element
near
innat
respons
promot
present
anim
model
found
nhp
thu
nhp
play
import
role
address
specif
aspect
humanspecif
mtb
infect
address
model
two
primari
macaqu
speci
commonli
use
tb
research
rhesu
macaqu
macaca
mulatta
cynomolgu
macaqu
macaca
fasciculari
addit
immunolog
similar
rang
infect
outcom
clinic
present
patholog
macaqu
remark
similar
human
tb
although
two
macaqu
speci
genet
similar
differ
resist
mtb
infect
rhesu
macaqu
suscept
develop
activ
tb
similarli
infect
cynomolgu
macaqu
author
unpublish
data
virul
strain
mtb
eg
erdman
almost
adult
rhesu
macaqu
develop
activ
tb
often
extrapulmonari
diseas
even
low
dose
infect
mehra
et
al
describ
model
latent
infect
rhesu
macaqu
model
reli
use
rel
lowvirul
mtb
strain
contrast
cohort
adult
cynomolg
macaqu
infect
low
dose
cfu
virul
mtb
erdman
strain
via
bronchoscop
instil
develop
equal
proport
anim
activ
tb
latent
infect
reason
increas
suscept
mtb
infect
develop
activ
tb
rhesu
macaqu
current
known
genet
similar
nhp
provid
opportun
learn
innat
adapt
mechan
mtb
infect
control
clinic
criteria
distinguish
activ
tb
latent
infect
nhp
base
human
clinic
definit
activ
tb
defin
clinic
sign
diseas
eg
cough
weight
loss
elev
erythrocyt
sediment
rate
esr
cultur
mtb
gastric
aspir
ga
bronchoalveolar
lavag
bal
contrast
anim
latent
infect
evid
infect
indic
posit
tuberculin
skin
test
tst
mtbspecif
immunolog
paramet
asymptomat
neg
mtb
cultur
ga
bal
month
post
infect
normal
esr
anim
activ
tb
becom
evid
month
post
infect
wherea
latent
infect
declar
least
month
post
infect
small
subset
anim
develop
sever
diseas
within
month
infect
term
rapid
progressor
pulmonari
diseas
common
form
activ
tb
seen
model
howev
form
human
extrapulmonari
tb
includ
brain
tuberculoma
uveiti
pott
diseas
tb
spondyl
liver
splenic
tb
observ
author
unpublish
data
spectrum
chronic
sever
activ
tb
human
cynomolgu
macaqu
shown
cynomolgu
macaqu
also
present
spectrum
latent
infect
like
contribut
risk
reactiv
diseas
coin
term
percol
describ
macaqu
otherwis
appear
latent
infect
asymptomat
normal
xray
normal
esr
intermitt
shed
mtb
cultur
ga
bal
spectrum
latent
infect
also
describ
human
especi
hivinfect
person
subclin
diseas
commonli
recogn
absenc
clinic
symptom
via
posit
releas
assay
igra
tst
normal
chest
xray
posit
mtb
sputum
reactiv
tb
latent
infect
occur
spontan
macaqu
incid
experi
experiment
induc
immun
suppress
demonstr
fidel
model
mimic
human
infect
rang
patholog
seen
macaqu
remark
similar
seen
human
true
strength
model
tubercul
granuloma
macaqu
human
organ
structur
immun
cell
form
respons
persist
mtb
infect
compos
larg
macrophag
lymphocyt
fig
one
primari
reason
develop
nhp
model
tb
access
granuloma
structur
similar
human
investig
local
immun
respons
way
perform
human
demonstr
macaqu
full
rang
granuloma
type
seen
human
classic
caseou
granuloma
observ
predominantli
lung
type
lung
granuloma
macaqu
includ
nonnecrot
granuloma
fibrot
calcifi
lesion
well
tb
pneumonia
caviti
consolid
interstiti
fibrosi
although
monkey
character
activ
tb
latent
infect
may
rang
granuloma
type
given
time
complex
patholog
tb
pneumonia
consolid
etc
seen
anim
activ
tb
divers
type
granuloma
within
individu
macaqu
like
import
determin
progress
diseas
reactiv
latent
infect
respons
drug
treatment
respect
latter
point
demonstr
mtb
bacilli
remain
short
cours
drug
therapi
case
month
almost
caseou
granuloma
suggest
granuloma
need
target
effect
therapi
infect
mtb
occur
upon
inhal
bacilli
perhap
even
singl
bacillu
human
mtb
enter
airway
like
innat
immun
factor
includ
alveolar
macrophag
surfact
antimicrobi
peptid
among
other
could
prevent
establish
infect
although
poorli
understood
estim
human
expos
mtb
becom
infect
although
risk
becom
infect
increas
physic
proxim
index
case
number
repeat
exposur
review
infect
establish
bacillu
like
enter
alveolar
macrophag
begin
replic
bacteria
transit
lung
parenchyma
continu
replic
macrophag
thu
set
slow
inflammatori
respons
recruit
macrophag
innat
cell
initi
granuloma
although
adapt
respons
requir
complet
granuloma
format
prime
tcell
respons
respiratori
virus
initi
lung
drain
lymph
node
respons
seen
within
day
mice
human
howev
initi
tcell
respons
mtb
infect
much
slower
human
macaqu
peripher
respons
mtb
infect
usual
take
week
detect
igra
tuberculin
skin
test
immunolog
measur
mice
infect
aerosol
mtb
cultur
mtb
present
singl
lungdrain
mediastin
lymph
node
day
post
infect
even
though
bacilli
cultur
lung
earli
day
postinfect
bhatt
et
al
show
bacilli
transfer
lymph
node
airway
via
dendrit
cell
howev
bacilli
also
like
transport
lung
granuloma
lungdrain
lymph
node
via
inflammatori
monocytemacrophag
dendrit
cell
mice
infect
lymph
node
correl
induct
tcell
respons
mtb
antigen
respons
observ
lymph
node
infect
day
postinfect
thu
rel
slow
immun
respons
mtb
seen
anim
model
human
follow
aerosol
exposur
may
relat
rel
slow
seed
lymph
node
mtb
mtb
antigen
subsequ
prime
tcell
respons
antigen
possibl
includ
slow
replic
rate
bacillu
compar
respiratori
virus
bacteria
low
initi
inoculum
suppress
dendrit
cell
macrophag
migrat
lymph
node
inhibit
tcell
prime
mtb
numer
studi
effect
mtb
dendrit
cell
cell
migrat
prime
cell
none
definit
prove
mtb
activ
interf
tcell
prime
studi
higher
mtb
inocula
normal
transgen
mice
lead
rapid
initi
tcell
respons
nonetheless
event
occur
earli
infect
human
remain
black
box
nhp
use
begin
dissect
event
translat
human
classic
ghon
complex
consist
initi
lung
granuloma
lungassoci
lymph
node
granuloma
like
human
macaqu
sever
mediastin
lymph
node
promin
hilar
lymph
node
carin
lymph
node
right
left
side
airway
fig
use
positron
emiss
tomographi
pet
computer
tomographi
ct
coupl
petct
probe
fluorodglucos
fdg
revolution
abil
examin
earli
event
lung
thorac
lymph
node
fdg
incorpor
retain
metabol
activ
cell
includ
area
inflamm
immun
cell
activ
thorac
lymph
node
becom
infect
earli
cours
infect
petct
imag
find
increas
uptak
fdg
subset
lymph
node
anim
week
infect
time
small
granuloma
also
reliabl
identifi
lung
lobe
fig
sinc
fdg
rel
nonspecif
pet
probe
label
metabol
activ
cell
fdg
avid
could
signifi
increas
inflamm
due
infect
lymph
node
simpli
initi
prolifer
tcell
respons
traffick
mtb
lung
lungdrain
lymph
node
well
understood
data
macaqu
infect
genet
barcod
mtb
strain
indic
granuloma
initi
singl
organ
lungdrain
lymph
node
contain
sever
differ
barcod
strain
could
reflect
initi
infect
airway
migrat
sever
differ
granuloma
lymph
node
divers
librari
genet
barcod
bacteria
current
use
address
question
thorac
lymph
node
rich
sourc
mtbspecif
cell
earli
mtb
infect
number
mtbspecif
cell
make
assess
elispot
assay
reliabl
detect
week
post
infect
substanti
higher
thorac
lymph
node
compar
granulomat
lung
time
approxim
cell
cell
activ
phenotyp
commonli
contrast
cell
blood
lung
differ
substanti
activ
marker
express
activ
cell
also
found
thorac
lymph
node
anim
activ
latent
tb
although
anim
activ
diseas
often
fewer
cell
lymph
node
tcell
region
effac
lymph
node
displac
caseou
granuloma
howev
substanti
produc
cell
lymph
node
anim
activ
diseas
compar
latent
infect
anim
differ
may
driven
bacteri
burden
similarli
greater
number
mtbspecif
cell
observ
blood
airway
granulomat
lung
anim
activ
diseas
rel
cell
similar
compart
latent
infect
anim
although
cell
within
compart
differ
activ
marker
chemokin
receptor
profil
petct
imag
allow
us
detect
follow
lesion
vivo
cours
infect
macaqu
fdg
appear
highlight
area
inflamm
associ
metabol
activ
cell
includ
neutrophil
macrophag
lymphocyt
granuloma
within
lung
lobe
strongli
fdgavid
littl
fdg
avid
suggest
wide
rang
inflamm
granuloma
fig
addit
visual
metabol
activ
petct
imag
reveal
size
spatial
orient
granuloma
use
follow
trajectori
cours
infect
fig
includ
identif
newli
form
granuloma
primari
infect
reactiv
tb
find
unpublish
contradict
longheld
assumpt
lung
diseas
lower
lobe
associ
primari
mtb
infect
upper
lobe
involv
reactiv
latent
infect
dogma
recent
refut
modern
molecular
techniqu
could
detect
remot
current
circul
strain
mtb
commun
studi
correl
found
radiograph
pattern
time
mtb
infect
importantli
fdg
petct
reveal
individu
granuloma
within
macaqu
dynam
time
independ
corrobor
data
petctimag
human
tb
clifton
barri
iii
person
commun
found
size
metabol
activ
spatial
tempor
distribut
lung
lesion
differ
evolut
anim
activ
tb
latent
infect
even
interest
earli
pattern
granuloma
number
develop
new
lesion
time
predict
outcom
infect
earli
week
post
infect
attribut
variabl
diseas
pattern
among
anim
bacteri
heterogen
individu
granuloma
gener
singl
bacillu
substanti
heterogen
bacteri
burden
earli
week
postinfect
dissemin
granuloma
differ
immunolog
respons
gideon
et
al
manuscript
review
granuloma
level
thu
total
sum
activ
individu
granuloma
burden
ultim
contribut
clinic
outcom
macaqu
human
granuloma
format
mediastin
lymph
node
enlarg
occur
mtb
infect
hilar
adenopathi
commonli
occur
children
hivinfect
person
tb
hilar
adenopathi
chest
xray
report
poulsen
adult
primari
mtb
infect
even
chemotherapi
era
review
hilar
adenopathi
reportedli
occur
reactiv
tb
case
howev
clear
reactiv
tb
determin
nonetheless
involv
mediastin
lymph
node
drain
lung
clearli
occur
human
nhp
extent
involv
cours
infect
may
variabl
note
migrat
mtb
lymph
node
via
macrophag
dendrit
cell
even
lymphat
blood
appear
necessari
step
prime
antimycobacteri
tcell
respons
howev
consequ
migrat
lymph
node
becom
infect
granuloma
format
occur
lymph
node
mtbinfect
macaqu
contain
singl
multipl
small
granuloma
complet
effac
caseou
granuloma
thu
lymph
node
reservoir
infect
studi
tb
drug
treatment
cynomolgu
macaqu
lymph
node
still
retain
signific
number
bacilli
shortterm
drug
therapi
lung
granuloma
easili
steril
studi
anim
clinic
latent
infect
suggest
lymph
node
signific
sourc
reactiv
author
unpublish
data
anim
latent
infect
experi
reactiv
tnf
neutral
show
histolog
sign
reactiv
diseas
lymph
node
includ
appear
satellit
granuloma
next
appear
older
granuloma
recent
unpublish
studi
use
petct
imag
reactiv
respons
tnf
neutral
occur
one
thorac
lymph
node
lung
granuloma
measur
increas
size
fdg
avid
anim
latent
infect
deplet
cell
half
cohort
develop
reactiv
tb
although
cell
deplet
peripher
macaqu
extent
deplet
thorac
lymph
node
variabl
howev
anim
reactiv
lowest
level
cell
lymph
node
data
support
lymph
node
signific
reservoir
mtb
infect
activ
tb
latent
infect
bacteri
replic
held
check
immun
pressur
import
lymphat
system
play
critic
role
establish
mtb
infect
bacteri
dissemin
also
discuss
detail
elsewher
lymph
node
also
contribut
diseas
worsen
patholog
macaqu
lymph
node
infect
becom
greatli
enlarg
necrot
sinc
lymph
node
posit
proxim
airway
massiv
enlarg
lead
compress
airway
possibl
result
collaps
emphysemat
lung
sever
case
affect
lymph
node
erod
airway
spread
infect
throughout
lung
situat
far
common
rhesu
macaqu
rare
seen
cynomolgu
macaqu
rhesu
macaqu
gener
extens
thorac
lymph
node
involv
compar
cynomolgu
macaqu
lymph
node
infect
extens
necrot
effac
lymph
node
respect
impress
lymph
node
involv
rhesu
macaqu
may
perhap
close
resembl
situat
pediatr
tb
also
signific
lymph
node
involv
cynomolgu
macaqu
may
repres
adult
tb
situat
although
may
lymph
node
involv
cynomolgu
macaqu
human
patholog
progress
infect
cynomolgu
macaqu
much
similar
seen
human
tb
cynomolgu
macaqu
latent
infect
nearli
alway
granuloma
often
calcifi
lymph
node
mani
case
ghon
complex
lung
lesion
associ
involv
lymph
node
identifi
real
strength
macaqu
model
tb
abil
perform
immun
modul
address
specif
question
mtb
infect
humanlik
system
show
cytokin
tnf
import
control
earli
infect
latent
infect
sever
key
featur
shown
model
repres
human
biolog
murin
model
mice
without
function
tnf
disorgan
granulomat
inflamm
wherea
cynomolgu
macaqu
treat
antitnf
neutral
antibodi
normal
granuloma
structur
although
granuloma
larger
size
granuloma
unmanipul
macaqu
outbr
genet
natur
cynomolgu
macaqu
anim
underw
tnf
neutral
time
challeng
develop
sever
diseas
within
week
suggest
tnf
import
macaqu
like
human
absolut
requir
tnf
control
earli
infect
human
antibodi
deliv
macaqu
week
tend
develop
respons
antibodi
thu
possibl
longer
cours
tnf
neutral
newli
infect
macaqu
would
result
anim
lose
control
abil
control
mtb
infect
studi
anim
latent
infect
treat
antitnf
antibodi
develop
gross
evid
reactiv
within
week
treatment
howev
even
macaqu
reactiv
overal
architectur
granuloma
remain
intact
despit
tnf
neutral
unusu
promin
extrapulmonari
diseas
tnf
neutralizationinduc
reactiv
uniqu
featur
given
reactiv
commonli
manifest
pulmonari
diseas
human
seen
macaqu
human
treat
tnfneutral
agent
observ
suggest
granuloma
still
appear
organ
function
prevent
dissemin
throughout
lung
organ
differ
product
observ
tnf
neutral
control
anim
alter
tcell
recruit
chemokin
receptor
lung
granuloma
lymph
node
notabl
peripher
respons
measur
pbmc
show
immun
respons
lung
lymph
node
owe
compartment
immun
respons
hiv
epidem
led
resurg
tb
cynomolgu
macaqu
provid
excel
research
model
end
stage
hiv
definit
associ
sever
reduc
level
cell
thought
primari
sourc
critic
cytokin
control
mtb
infect
mice
like
human
other
shown
cell
critic
control
earli
infect
macaqu
latent
infect
deplet
cell
antibodi
week
result
half
anim
develop
reactiv
tb
despit
loss
cell
control
infect
correl
decreas
product
suggest
loss
cell
may
result
suboptim
tcell
respons
simian
immunodefici
viru
siv
use
model
hiv
infect
rhesu
cynomolgu
macaqu
siv
infect
cynomolgu
macaqu
latent
infect
result
signific
shortliv
increas
frequenc
mycobacteriaspecif
cell
follow
reactiv
anim
period
month
time
reactiv
depend
earli
reduct
peripher
tcell
number
although
difficult
confirm
peripher
cytokin
perturb
observ
time
may
correl
increas
bacteri
replic
granuloma
deplet
protect
tcell
respons
tcell
number
rebound
peripheri
period
granuloma
taken
anim
week
postreactiv
normal
nearnorm
number
cell
case
granuloma
histolog
similar
granuloma
sivneg
monkey
interestingli
subset
granuloma
appear
undergon
heal
event
follow
reactiv
appear
phenotyp
similar
fibrot
granuloma
inh
rifampicintr
monkey
subsequ
studi
suggest
siv
could
inhibit
antigenpres
cell
induc
product
cytokin
therebi
inhibit
mtbspecif
tcell
respons
unpublish
studi
demonstr
deplet
cell
prior
mtb
infect
macaqu
prevent
control
earli
infect
lin
et
al
prepar
anoth
macaqu
studi
bcgassoci
protect
mtb
challeng
lost
cell
deplet
effect
tcell
deplet
similar
tcell
deplet
term
infect
dissemin
diseas
strongli
suggest
tcell
subset
essenti
control
earli
infect
inflamm
posit
featur
immun
respons
also
neg
consequ
publish
unpublish
data
inflamm
seem
correl
worsen
diseas
macaqu
although
evid
murin
model
suggest
antiinflammatori
mediat
regulatori
cell
treg
detriment
control
mtb
infect
review
also
sever
studi
suggest
lack
control
tcell
respons
lead
exacerb
diseas
exampl
mice
defici
signal
molecul
involv
exhaust
cell
rapid
onset
lung
inflamm
death
mtb
infect
suggest
without
downregul
tcell
respons
lung
inflamm
result
worsen
diseas
human
macaqu
gideon
et
al
manuscript
prepar
inflammatori
neutrophiltyp
ifn
respons
observ
anim
activ
tb
cynomolgu
macaqu
found
higher
level
treg
blood
prior
infect
correl
improv
outcom
ie
latent
infect
vs
activ
tb
within
first
week
infect
treg
blood
infect
monkey
rapidli
deplet
concomit
increas
treg
airway
find
suggest
migrat
treg
lung
may
import
limit
initi
inflamm
studi
potenti
antiinflammatori
factor
hostdirect
therapi
undertaken
humanlik
macaqu
model
move
human
trial
sinc
effect
modul
inflammatori
respons
control
local
lung
lymph
node
level
hard
predict
human
studi
reli
primarili
peripher
blood
tcell
respons
understand
immun
respons
vaccin
candid
drug
treatment
immun
respons
cours
mtb
infect
howev
lung
granuloma
provid
us
better
measur
actual
respons
induc
mtb
site
diseaseinfect
relationship
tcell
respons
blood
lung
tissu
complex
nhp
model
provid
excel
platform
investig
system
limit
data
laboratori
suggest
anim
establish
activ
diseas
latent
infect
system
tcell
respons
accur
reflect
local
tcell
respons
gideon
et
al
manuscript
review
even
bal
tcell
respons
consid
closer
match
lung
tcell
respons
differ
respons
see
granuloma
differ
tcell
respons
might
complic
due
exist
spectrum
infect
local
system
level
nonhuman
primat
human
thu
caution
use
interpret
extrapol
data
peripher
tcell
respons
human
respons
lung
cynomogu
macaqu
provid
excel
model
studi
function
aspect
immunolog
compon
tb
granuloma
recent
studi
lab
indic
anim
substanti
variabl
type
number
granuloma
fig
well
bacteri
burden
within
individu
granuloma
irrespect
whether
develop
clinic
activ
tb
latent
infect
spectrum
granuloma
activ
tb
latent
infect
extrem
similar
observ
human
tb
recent
studi
group
find
progress
heal
lesion
coexist
within
anim
nearli
anim
capabl
steril
least
subset
individu
granuloma
howev
anim
activ
tb
present
subset
lesion
control
infect
result
dissemin
infect
develop
complex
patholog
tb
pneumonia
caviti
consolid
number
viablecultur
mtb
bacilli
individu
granuloma
rang
even
within
individu
anim
steril
cfugranuloma
cfugranuloma
overlap
substanti
among
monkey
activ
tb
latent
infect
gideon
et
al
manuscript
review
bacteri
burden
individu
granuloma
greatest
among
anim
infect
week
observ
substanti
reduct
bacteri
burden
week
postinfect
coincid
onset
adapt
immun
respons
howev
substanti
rang
bacteri
burden
within
anim
suggest
extent
bacteri
contain
vari
among
granuloma
therefor
mere
presenc
granuloma
insuffici
control
infect
instead
proper
function
granuloma
host
determin
ultim
outcom
infect
current
avail
data
support
hypothesi
outcom
mtb
infect
determin
granuloma
level
sum
total
granuloma
chanc
either
inhibit
permit
bacteri
dissemin
collect
respons
diseas
total
host
level
complex
organ
granuloma
popul
macrophag
lymphocyt
suggest
signific
crosstalk
cell
type
granuloma
function
properli
need
coordin
cell
type
proper
balanc
activ
inhibitori
signal
yet
clarifi
mani
question
remain
contribut
success
contain
bacteria
granuloma
progress
dissemin
address
major
player
granuloma
biolog
well
potenti
function
macrophag
major
compon
macaqu
human
granuloma
act
antibacteri
effector
cell
host
cell
bacteria
immunomodul
cell
nitric
oxid
synthas
no
arginas
arg
import
enzym
macrophag
respons
mtb
infect
induc
no
ino
convert
larginin
nitric
oxid
reactiv
product
act
concert
reactiv
oxygen
intermedi
kill
microb
mani
cell
type
includ
epitheli
cell
author
unpublish
data
neutrophil
express
ino
macaqu
granuloma
ino
frequent
associ
classic
activ
macrophag
macrophag
although
macaqu
macrophag
make
granuloma
contain
activ
no
enzym
singlecel
basi
macaqu
macrophag
express
ino
quantit
lower
level
seen
mous
macrophag
role
ino
human
tb
controversi
remain
question
whether
macrophag
ino
enhanc
kill
mtb
act
immunomodul
contribut
patholog
bacteri
dissemin
likelihood
consequ
ino
express
granuloma
encompass
option
depend
granuloma
inflammatori
state
epithelioid
macrophag
also
express
endotheli
no
eno
although
function
eno
cell
remain
elucid
coexpress
ino
suggest
may
augment
product
popul
cell
no
activ
regul
competit
larginin
enzym
convert
larginin
polyamin
precursor
lprolin
amino
acid
need
collagen
synthesi
contributor
fibrot
process
lesion
resolut
line
evid
suggest
macrophag
arginas
requir
fibrosi
regul
tcell
respons
engag
current
unidentifi
antibacteri
activ
human
macaqu
granuloma
neutrophil
express
macrophag
express
signific
quantiti
macrophag
describ
altern
activ
macrophag
macrophag
sometim
consid
distinct
cell
subset
ino
often
coexpress
macrophag
macaqu
granuloma
competit
enzym
ratio
ino
express
like
determin
macrophag
function
polar
granuloma
need
maxim
bacteri
kill
limit
immun
patholog
adjac
tissu
spatial
organ
differ
macrophag
subset
may
help
mediat
balanc
context
nhp
granuloma
organ
special
microenviron
region
function
charact
determin
abund
macrophag
lymphocyt
cuff
rel
bacilli
found
contain
larg
popul
macrophag
low
ino
ratio
wherea
epithelioid
macrophagedomin
region
associ
greater
number
mtb
macrophag
higher
ino
ratio
base
observ
hypothes
macrophag
lymphocyt
cuff
protect
nearbi
tissu
immun
patholog
produc
precursor
lesion
resolut
ino
eno
epithelioid
macrophag
bacteriarich
microenviron
special
nomedi
bactericid
activ
although
appear
gener
properti
granuloma
exhibit
granuloma
dynam
macrophag
popul
phenotyp
like
undergo
signific
chang
cours
infect
lymphocyt
major
cellular
compon
tuberculosi
lung
granuloma
macrophageactiv
cytolyt
activ
consid
critic
control
initi
persist
mtb
infect
proinflammatori
cytokin
tnf
gener
consid
necessari
protect
proinflammatori
cytokin
may
stimul
prolifer
activ
local
cell
recruit
cell
peripheri
role
antiinflammatoryregulatori
cytokin
granuloma
controversi
antiinflammatori
cytokin
may
import
reduc
patholog
granuloma
cell
also
express
cytolyt
antimicrobi
factor
includ
perforin
granzym
b
granulysin
author
unpublish
data
interestingli
granuloma
cell
appear
exhibit
segreg
function
cell
either
cytokin
produc
cytolyt
cell
rare
recent
studi
investig
function
dynam
cell
respect
cytokin
profil
bacteri
burden
individu
granuloma
shown
granuloma
independ
respect
total
cell
number
frequenc
cell
pattern
cytokin
respons
bacteri
burden
within
individu
host
amongst
anim
gideon
et
al
manuscript
review
data
suggest
individu
granuloma
within
host
uniqu
represent
infect
classifi
activ
latent
instead
convent
clinic
classif
activ
diseas
latent
infect
appropri
global
whole
host
classif
reflect
overal
host
statu
infect
patholog
observ
tcell
cytokin
profil
individu
granuloma
within
singl
anim
distinct
highli
variabl
overlap
consider
across
clinic
diseas
statu
gideon
et
al
manuscript
review
due
recruit
activ
cell
site
diseas
mtbspecif
tcell
respons
thought
enrich
granuloma
compar
respons
observ
peripher
blood
contrast
observ
limit
proport
cell
granuloma
produc
major
cytokin
examin
tnf
respons
mtb
antigen
irrespect
granuloma
bacteri
burden
clinic
diseas
statu
anim
gideon
et
al
review
result
corrobor
elispot
analysi
granuloma
cell
give
compar
even
lower
frequenc
cell
produc
author
unpublish
data
beg
question
granuloma
tcell
respons
low
sever
possibl
unexpect
low
frequenc
function
cell
observ
granuloma
includ
presenc
addit
regulatori
cytokin
cell
includ
regulatori
cell
exhaust
cell
within
granuloma
result
chronic
antigen
exposur
presenc
cell
migrat
granuloma
respons
chemokin
cytokin
gradient
specif
mycobacteri
antigen
activ
downregul
tcell
respons
mycobacteri
factor
major
question
rais
studi
whether
enhanc
function
tcell
respons
particularli
earli
phase
infect
set
vaccin
respons
would
lead
increas
kill
bacilli
increas
inflamm
fact
data
suggest
balanc
cytokin
respons
proand
antiinflammatori
best
correl
bacteri
control
gideon
et
al
manuscript
review
protect
benefit
antibodymedi
humor
respons
tb
controversi
whether
contribut
protect
b
cell
includ
plasma
cell
human
nhp
granuloma
activ
b
cell
germin
centerlik
cluster
commonli
observ
lymphocyt
cuff
cynomolgu
macaqu
granuloma
antibodi
specif
mtb
antigen
enrich
granuloma
well
although
influenc
antibodi
exert
control
infect
investig
studi
murin
model
suggest
antibodi
could
play
immunomodulatori
role
mtb
infect
perhap
interact
activatori
inhibitori
receptor
macrophag
review
nhp
granuloma
b
cell
also
produc
cytokin
author
unpublish
data
bcell
contribut
granuloma
cytokin
milieu
remain
determin
role
neutrophil
tb
remain
enigmat
neutrophil
play
protect
role
earli
zebrafish
granuloma
littl
known
activ
acut
mtb
infect
nhp
later
stage
diseas
neutrophil
often
associ
poorli
control
tb
abund
granuloma
especi
interfac
epithelioid
macrophag
caseum
also
present
lymphocyt
cuff
neutrophil
present
larg
number
bacteriarich
area
necrot
granuloma
frequent
seen
lymph
node
granuloma
complex
patholog
anim
sever
diseas
abil
control
bacteri
replic
question
data
indic
neutrophil
human
bal
sampl
contain
viabl
mtb
suggest
cell
may
kill
mtb
may
even
provid
addit
intracellular
nich
mtb
though
abil
kill
bacilli
situ
question
neutrophil
may
function
influenc
granuloma
environ
includ
secret
proteas
cytokin
nitric
oxid
product
immunomodul
arginas
express
vaccin
primari
strategi
sustain
control
infecti
diseas
although
vaccin
tb
bcg
exist
given
children
countri
birth
effect
prevent
infect
subsequ
diseas
vaccin
improv
efficaci
necessari
stem
tide
tb
worldwid
lack
surrog
marker
protect
major
obstacl
develop
vaccin
tb
date
wellestablish
indic
vaccineinduc
reduct
bacteri
load
use
anim
model
go
human
trial
import
distinct
must
made
vaccineinduc
immunogen
yet
correl
protect
vaccin
clinic
trial
primarili
aim
induc
tcell
respons
effect
induc
strong
tcell
respons
even
though
believ
respons
necessari
protect
natur
infect
potenti
induc
antibodi
respons
might
protect
fulli
explor
thu
better
understand
vaccin
might
work
prevent
infect
diseas
necessari
nhp
model
critic
effort
immunolog
similar
human
nonhuman
primat
like
lead
result
translat
human
clinic
trial
nonetheless
nonhuman
primat
studi
expens
difficult
differ
model
give
differ
answer
previous
vaccin
test
rhesu
cynomolgu
macaqu
challeng
high
dose
mtb
bacilli
high
dose
challeng
bear
littl
resembl
situat
exposur
mtb
human
like
occur
rel
small
dose
period
time
exampl
household
contact
sleep
next
person
activ
tb
like
expos
small
number
aerosol
mtb
sever
hour
nightli
sever
week
index
case
infect
recogn
treatment
initi
none
current
model
accur
recapitul
situat
howev
low
dose
challeng
like
much
relev
high
dose
challeng
test
vaccin
low
dose
challeng
eg
bacilli
like
set
moder
inflammatori
respons
may
result
modest
detect
bacilli
immun
system
contrast
high
dose
challeng
induc
inflammatori
respons
possibl
caus
faster
tcell
recal
respons
site
infect
could
potenti
result
find
support
efficaci
vaccin
might
difficult
observ
respons
low
dose
infect
conclus
demonstr
even
test
macaqu
howev
clear
low
dose
infect
accur
reflect
situat
occur
human
therefor
like
appropri
model
test
vaccin
sever
vaccin
test
macaqu
includ
viralvector
vaccin
live
attenu
vaccin
bcg
leucddelet
mtb
mtbvac
proteinbas
vaccin
shown
modest
reduct
diseas
bacteri
burden
done
high
dose
challeng
test
proteinfus
vaccin
bcgvaccin
cynomolgu
macaqu
follow
low
dose
challeng
mtb
fewer
anim
develop
activ
tb
compar
unvaccin
bcgonli
vaccin
anim
also
seen
follow
high
dose
challeng
studi
perform
primat
facil
cebu
philippin
howev
interest
aspect
work
monkey
vaccin
present
latent
infect
could
reactiv
tnf
neutral
contrast
unvaccin
bcgonli
immun
macaqu
develop
latent
infect
show
reactiv
tnf
neutral
thu
even
though
vaccin
provid
steril
immun
capabl
prevent
reactiv
latent
infect
mechan
behind
protect
current
investig
publish
data
suggest
vaccin
associ
earlier
recal
respons
antigen
postchalleng
compar
unvaccin
bcgonli
vaccin
anim
howev
immunolog
respons
within
granuloma
assess
earli
postinfect
import
understand
effect
vaccin
earli
event
lung
postchalleng
overst
futur
test
vaccin
macaqu
model
take
full
advantag
technolog
advanc
includ
abil
track
infect
use
genet
barcod
mtb
strain
petct
imag
sophist
immunolog
analysi
blood
airway
lung
parenchyma
granuloma
lymph
node
studi
like
illumin
mechan
vaccin
provid
measur
protect
suggest
area
improv
hostdirect
therapi
small
molecul
cytokin
modul
immun
respons
substanti
interest
tb
well
immunolog
modul
could
dampen
enhanc
inflammatori
tcell
respons
tb
could
limit
cours
infect
howev
understand
littl
modul
includ
whether
could
actual
worsen
diseas
hostdirect
therapi
may
role
improv
drug
treatment
enhanc
vaccin
efficaci
much
focu
hostdirect
therapi
necessari
nhp
model
accur
reflect
complex
patholog
mtb
infect
test
strategi
human
tb
nhp
model
tb
provid
uniqu
excit
opportun
investig
immunolog
tb
similar
human
macaqu
genet
physiolog
immunolog
provid
greater
confid
direct
translat
key
find
human
although
model
alway
improv
refin
learn
much
nonhuman
primat
tb
field
expect
futur
find
also
significantli
influenc
develop
prevent
therapeut
strategi
tb
immunohistochem
stain
necrot
granuloma
show
macrophag
green
surround
necrot
center
unstain
cell
red
lymphocyt
cuff
scatter
cluster
alveolar
macrophag
character
morpholog
strong
express
seen
edg
granuloma
adjac
lung
tissu
nuclei
stain
blue
magnif
increas
uptak
fdg
observ
cranial
hilar
carin
lymph
node
yellow
arrow
small
lung
granuloma
blue
arrow
variabl
fdg
uptak
also
observ
earli
week
post
infect
nhp
variou
type
number
lung
granuloma
observ
variabl
fdg
uptak
within
lobe
activ
diseas
latent
infect
arrow
indic
metabol
activepet
hot
yellow
pet
cold
blue
granuloma
seen
within
lobe
